Gene editingTessaly sues two startups, alleging theft of gene editing trade secretsThe complaint says a former scientist took confidential designs and helped launch a competing rare disease program. Both defendants deny the claims.Sept. 21, 2026·Gene Therapy
Marrow Peak falls on four-year data for its Huntington's gene therapyDisease progression slowed by 41% compared with a matched external group, down from 60% at the three-year mark.Sept. 19, 2026·Gene Therapy
Immune resetAn off-the-shelf cell therapy shows early promise against lupusNine of eleven patients in a first trial were in remission without medication six months after a single infusion.Sept. 12, 2026·Gene Therapy
